Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro - Wikidata - wikimedia - TriplyDB

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro

http://www.wikidata.org/entity/Q36760929

about

Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity Current progress in gene delivery technology based on chemical methods and nano-carriers Cationic PAMAM dendrimers disrupt key platelet functions.Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia.Evaluating platelet aggregation dynamics from laser speckle fluctuations.Selective aggregation of PAMAM dendrimer nanocarriers and PAMAM/ZnPc nanodrugs on human atheromatous carotid tissues: a photodynamic therapy for atherosclerosis.Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment Biotargeted nanomedicines for cancer: six tenets before you begin Efficient GSH delivery using PAMAM-GSH into MPP-induced PC12 cellular model for Parkinson's disease.Impact of Dendrimer Terminal Group Chemistry on Blockage of the Anthrax Toxin Channel: A Single Molecule Study.Nanoparticles and the blood coagulation system. Part II: safety concerns.Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish Dendrimer-conjugated peptide vaccine enhances clearance of Chlamydia trachomatis genital infection.Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.Nanoparticle dosage-a nontrivial task of utmost importance for quantitative nanosafety research.The effects of nanomaterials on blood coagulation in hemostasis and thrombosis.Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry.CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility.Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors.Cationic PAMAM dendrimers aggressively initiate blood clot formation.Matrix Metalloproteinase Responsive, Proximity-activated Polymeric Nanoparticles for siRNA Delivery.In vivo safety evaluation of polyarginine coated magnetic nanovectors.Tuning cellular response to nanoparticles via surface chemistry and aggregation.Metallic oxide nanoparticles stimulate blood coagulation independent of their surface charge.In Vitro Assessment of Nanoparticle Effects on Blood Coagulation.Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo.Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.Effects of Polyamidoamine Dendrimers on a 3-D Neurosphere System Using Human Neural Progenitor Cells.Dendritic polymers for dermal drug delivery.Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.Dual-functionalized poly(amidoamine) dendrimers with poly(ethylene glycol) conjugation and thiolation improved blood compatibility.Quantitative analysis of PEG-functionalized colloidal gold nanoparticles using charged aerosol detection.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.

P2860

Q27303181-FEBE9BAE-5A30-4057-8C13-E49D831970E6 Q28081577-537EF2A7-5B70-4635-8533-353562D3553E Q28386730-83E17885-4259-4D1C-AA63-949B8C4AF913 Q28659480-034743A5-E5D6-4DB3-9A3D-A84803B6E1CF Q30514562-6C7951EC-F834-4973-B1B4-729A23CAF1AB Q33600393-F1A845BE-B57A-4692-9436-C94043E56AB3 Q33610514-438EBB90-066A-478B-9CFF-C2FED501FFDE Q33901678-F181B315-6801-4F60-8B30-AADC3AA30E85 Q35607240-08D73D2C-FF9D-43CD-800A-99DFCE299D36 Q36403660-5F7948F5-CBB0-4585-BA56-6C85CA620852 Q36654099-D5674BE1-C7AB-438B-BA42-55E78F1AE393 Q36814280-B9BD8A7E-22F6-4926-8216-A56A55B820DB Q37298397-99279D7C-C978-4D38-BEF5-78FB3BC54CDB Q37450447-4C46CE25-EF05-478A-8E76-D262461DD5F4 Q37612053-45E55527-09D0-489D-80F0-BB73F7DF36F4 Q37724132-DB9843BC-B20F-48C7-A8E9-680461356F5C Q37834084-DC7CF0A7-D70A-4DAD-A3AC-9AD294AA6376 Q38112504-B2E9A82E-C11F-45A6-9E2B-752B12FD0D1B Q38264255-B9B3DA4B-CB80-4824-9516-A7DED6DA641D Q38494470-BBA41A18-3722-4E7D-9C79-A6AF8BD62C7E Q38495085-DECC749F-9FCF-4C00-ADAB-536A8B435FF7 Q38641001-13DB1A8D-7E4D-473F-AF61-D3F5A7FE5475 Q39081782-18EE94BF-7091-46A4-BD45-A81DC0F9116B Q39121977-B1AF53F0-B9EF-439D-887E-2BC05EB03FD3 Q39620217-697742A3-5D24-41C4-95B5-E1EB8617C148 Q41901324-88F63A5C-8C0B-4F35-9757-120DAEF0BF49 Q42008916-FF5D818D-C9BF-4133-B530-31773FCE0E5D Q42077942-762FE7D5-CA38-45BB-ABDC-E7FEDCFC866E Q42117571-AA6B5AB5-96BC-40FD-AF48-C754D8537699 Q44522517-99CF2183-E21F-4204-B207-B7575995E476 Q45860863-4066EFF7-458B-4FD3-BB7A-6D3CECB556FA Q47642409-84B2B363-471C-462C-8338-B1E340EC0895 Q47729841-1154161C-62F7-41F6-9EAE-33326BDD1125 Q48168170-A932AD3C-51B4-46ED-9F86-85FC09F69713 Q48786835-5CAF906C-A077-4832-A34E-E78D89877DEB Q50073512-A8B80C3D-94E5-4215-935F-51D473FB4A8F Q50510408-ABE2E475-BF69-4541-A790-1FE5F50ABCF0 Q50943026-26EFEF18-1677-4789-997D-318FA66A0EA3 Q53591003-0091D1CC-8E3F-41D1-AD98-3BF508329F1A Q53755427-37B95707-E13F-42C3-81F9-16146CADFF13

P2860

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro

http://www.wikidata.org/entity/Q36760929

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Nanoparticle size and surface ...... rs on human platelets in vitro

@ast

Nanoparticle size and surface ...... rs on human platelets in vitro

@en

type

label

Nanoparticle size and surface ...... rs on human platelets in vitro

@ast

Nanoparticle size and surface ...... rs on human platelets in vitro

@en

prefLabel

Nanoparticle size and surface ...... rs on human platelets in vitro

@ast

Nanoparticle size and surface ...... rs on human platelets in vitro

@en

P1433

Q36760929-90E15067-108F-4682-B185-84ED69BAFDDE

P1476

Q36760929-8FBBC638-3504-449E-B1A3-8D5B87B1F685

P2093

Q36760929-22C96BB0-9B4E-491A-B7F4-7654C7A75356

Q36760929-327E6C30-2CC3-4DBD-B493-917DBA4A3111

Q36760929-7C3E3E04-7AE8-4D3F-93AA-0E9544EAB955

Q36760929-9D868941-806B-4BF5-A400-B2F6DBABB421

Q36760929-9EA8E6FD-3E68-4856-AFDE-B11574D6850F

Q36760929-BB4859D7-39FE-4DC7-9563-626E652AFAEA

Q36760929-F35E5502-E352-47C9-AC7B-AAA5C2F6BDEB

P2860

Q36760929-0870BF6A-5804-42D9-AF1D-0B8F5F9A8EAE

Q36760929-09372D9D-0F20-414F-99E2-C2A32543B6CF

Q36760929-0F7078D7-D050-4536-BEFC-880BC9396C50

Q36760929-2BA0B60C-A3C2-4DE8-8405-CE4DBD7ABEFA

Q36760929-346F6F64-27AF-48BB-9CDD-82ECB3BD4F4C

Q36760929-38892FFB-D65F-4151-9365-79C28E9429DA

Q36760929-39DC05C3-A741-4EE0-8F49-246FC7AB7C10

Q36760929-4B03F318-B72C-4C1A-8853-2958B8C6E582

Q36760929-4C60BE71-012D-4765-A25A-2017C89DD447

Q36760929-4F277F5F-4233-4637-B6F9-950E1F231EA7

P304

Q36760929-ABDC7C9A-187B-4FD1-A6D6-F26AC988FCC0

P31

Q36760929-D8BDEA71-6580-47CF-8C28-1AAEF0A13FB6

P356

Q36760929-B5E44937-5194-491D-B085-0CF44A6F8EF2

P407

Q36760929-11ED72B2-7F15-4375-8514-F54D5D083F95

P433

Q36760929-B0C0110F-EE5D-4F9A-8AED-C7B413AF9C2E

P478

Q36760929-25495173-A0C6-4999-91C7-82D8B0C437B0

P577

Q36760929-FCA567CB-0FA3-46F2-9AE1-662D5FC5325B

P5875

Q36760929-E8C8C4BB-127D-4B3F-BA4E-4FCCF9E00E61

P698

Q36760929-7CC5A401-B980-457A-89B2-5F504BAF77F4

P921

Q36760929-76E206F5-A441-4E91-BE45-95B196507F13

P932

Q36760929-A0C49B51-F82F-4E09-89AB-5B767F7B646D

P356

P1433

Molecular Pharmaceutics

P1476

Nanoparticle size and surface ...... rs on human platelets in vitro

@en

P2093

Anil K Patri

http://www.w3.org/2001/XMLSchema#string

Jan Simak

http://www.w3.org/2001/XMLSchema#string

Jana Semberova

http://www.w3.org/2001/XMLSchema#string

Jennifer B Hall

http://www.w3.org/2001/XMLSchema#string

Marina A Dobrovolskaia

http://www.w3.org/2001/XMLSchema#string

Scott E McNeil

http://www.w3.org/2001/XMLSchema#string

Silvia H De Paoli Lacerda

http://www.w3.org/2001/XMLSchema#string

P2860

Nanoparticle-induced platelet aggregation and vascular thrombosis

In vitro assessments of nanomaterial toxicity

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

Antithrombogenic properties of bioconjugate streptokinase-polyglycerol dendrimers.

Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.

Nanoscale protein pores modified with PAMAM dendrimers.

New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

In quest of a systematic framework for unifying and defining nanoscience

P304

382-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP200463E

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51744688

http://www.w3.org/2001/XMLSchema#string

P698

22026635

http://www.w3.org/2001/XMLSchema#string

P921

P932

3624701

http://www.w3.org/2001/XMLSchema#string